A Nanoparticle Delivery of Plasmid Encoding Hepatocyte Growth Factor for Gene Therapy of Silicosis in Mice
Purpose: Silicosis is a serious occupational disease that is characterized by pulmonary infiltrates and fibrosis and is often refractory to current treatments. New therapeutic strategies for silicosis are needed. Hepatocyte growth factor (HGF) is a latent anti-inflammatory and anti-fibrotic growth...
Guardado en:
Autores principales: | Haiying Duan, Peng Gao, Xiaochen Cheng, Yuxin Lu, Chunsheng Hu, Xuefeng Zhu, Xiaoying Wang, Dujuan Li, Fengjun Xiao, Li Du, Yunmei Liu, Qinglin Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Canadian Society for Pharmaceutical Sciences
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/95358139842343ea98b0a4e0ce378361 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Guest editorial: The ten most important qualities for the profession of medicinal research
por: Tony Y. Zhang
Publicado: (2021) -
Correction: Structural Racism and Supporting Black Lives – A Pharmacist’s Vow amid COVID-19
por: Nicole D. Avant
Publicado: (2021) -
An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems
por: Manal Mohammed Younus, et al.
Publicado: (2021) -
Pharmacy-Based Point-of-Care Testing: How a “Standard of Care” Approach Can Facilitate Sustainability
por: Alex J. Adams, et al.
Publicado: (2021) -
Self-Medication in Africa during COVID-19 Pandemic
por: Zainab Ismail, et al.
Publicado: (2021)